Hangzhou Tigermed Consulting Company Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
11,000
- Stock Symbol
-
300347
- Investments
-
104
- Share Price
-
$7.18
- (As of Friday Closing)
Hangzhou Tigermed Consulting Company General Information
Description
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
Contact Information
Website
www.tigermed.netCorporate Office
- Securities Affairs Department, 19th Floor, Building A, Shengda Science and Technology Park
- Number 19 Jugong Road, Binjiang District
- Hangzhou, Zhejiang 310051
- China
Corporate Office
- Securities Affairs Department, 19th Floor, Building A, Shengda Science and Technology Park
- Number 19 Jugong Road, Binjiang District
- Hangzhou, Zhejiang 310051
- China
Hangzhou Tigermed Consulting Company Stock Performance
As of 13-Nov-2026, Hangzhou Tigermed Consulting Company’s stock price is $7.18. Its current market cap is $5.83B with 855M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.18 | $7.33 | $5.26 - $9.80 | $5.83B | 855M | 13.9M | -$0.07 |
Hangzhou Tigermed Consulting Company Financials Summary
As of 30-Sep-2026, Hangzhou Tigermed Consulting Company has a trailing 12-month revenue of $1.1B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 7,735,448 | 7,165,231 | 6,786,986 | 6,313,619 |
| Revenue | 1,102,394 | 950,146 | 920,236 | 1,043,698 |
| EBITDA | (30,418) | 195,418 | 144,885 | 379,408 |
| Net Income | (58,699) | 123,467 | 56,462 | 286,203 |
| Total Assets | 4,174,682 | 4,053,167 | 3,927,483 | 4,187,109 |
| Total Debt | 330,830 | 239,570 | 388,157 | 478,320 |
Hangzhou Tigermed Consulting Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hangzhou Tigermed Consulting Company Comparisons
Industry
Financing
Details
Hangzhou Tigermed Consulting Company Competitors (21)
One of Hangzhou Tigermed Consulting Company’s 21 competitors is North American Science Associates, a Private Equity-Backed company based in Toledo, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| Theorem Clinical Research | Formerly PE-Backed | King of Prussia, PA | ||||
| Icon (Dublin) | Corporation | Dublin, Ireland | ||||
| Premier Research | Private Equity-Backed | Morrisville, NC | ||||
| ProPharma Group | Private Equity-Backed | Raleigh, NC |
Hangzhou Tigermed Consulting Company Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hangzhou Tigermed Consulting Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hangzhou Tigermed Consulting Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hangzhou Tigermed Consulting Company Investments & Acquisitions (104)
Hangzhou Tigermed Consulting Company’s most recent deal was a Early Stage VC with Taya Language Technology for . The deal was made on 15-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Taya Language Technology | 15-Oct-2026 | Early Stage VC | Enterprise Systems (Healthcare) | ||
| Forward Pharma (Drug Discovery) | 30-Jul-2026 | Later Stage VC | Drug Discovery | ||
| Angel Pharmaceuticals | 10-Jun-2026 | Later Stage VC | Drug Discovery | ||
| Longivitron | 03-Jun-2026 | Early Stage VC | Drug Discovery | ||
| Haihe Biopharma | 01-Mar-2026 | Secondary Transaction - Private | Drug Discovery |
Hangzhou Tigermed Consulting Company ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
14.84 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Hangzhou Tigermed Consulting Company Exits (26)
Hangzhou Tigermed Consulting Company’s most recent exit was on 27-Sep-2024 from Teddy Lab Services. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Teddy Lab Services | 27-Sep-2024 | Completed |
|
||
| PegBio | 24-Jun-2023 | Completed |
|
||
| Luzhu Biotech | 31-Aug-2021 | Completed |
|
||
| 3D Medicines | 01-Jun-2021 | Completed |
|
||
| CANbridge Pharma | 21-May-2021 | Later Stage VC | Completed |
|
Hangzhou Tigermed Consulting Company Affiliates
Subsidiaries (8)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Medical Edge (Enterprise Systems (Healthcare)) | Chiyoda-ku, Japan | 2015 | |
| Clinflash | Jiaxing, China | 2014 | |
| TigerYeah Capital | Hangzhou, China | 2014 | |
| Marti Farm | Zagreb, Croatia | 2011 | |
| Micron ( Other Healthcare Services) | Minato-ku, Japan | 2005 |
Hangzhou Tigermed Consulting Company FAQs
-
When was Hangzhou Tigermed Consulting Company founded?
Hangzhou Tigermed Consulting Company was founded in 2004.
-
Where is Hangzhou Tigermed Consulting Company headquartered?
Hangzhou Tigermed Consulting Company is headquartered in Hangzhou, China.
-
What is the size of Hangzhou Tigermed Consulting Company?
Hangzhou Tigermed Consulting Company has 11,000 total employees.
-
What industry is Hangzhou Tigermed Consulting Company in?
Hangzhou Tigermed Consulting Company’s primary industry is Pharmaceuticals.
-
Is Hangzhou Tigermed Consulting Company a private or public company?
Hangzhou Tigermed Consulting Company is a Public company.
-
What is Hangzhou Tigermed Consulting Company’s stock symbol?
The ticker symbol for Hangzhou Tigermed Consulting Company is 300347.
-
What is the current stock price of Hangzhou Tigermed Consulting Company?
As of 13-Nov-2026 the stock price of Hangzhou Tigermed Consulting Company is $7.18.
-
What is the current market cap of Hangzhou Tigermed Consulting Company?
The current market capitalization of Hangzhou Tigermed Consulting Company is $5.83B.
-
What is Hangzhou Tigermed Consulting Company’s current revenue?
The trailing twelve month revenue for Hangzhou Tigermed Consulting Company is $1.1B.
-
Who are Hangzhou Tigermed Consulting Company’s competitors?
North American Science Associates, Theorem Clinical Research, Icon (Dublin), Premier Research, and ProPharma Group are some of the 21 competitors of Hangzhou Tigermed Consulting Company.
-
What is Hangzhou Tigermed Consulting Company’s annual earnings per share (EPS)?
Hangzhou Tigermed Consulting Company’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
